Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

Clinical trial NCT00240292 · COMPLETED

Trial details

NCT number: NCT00240292
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure, Congestive

Start date: 2003-02-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.